| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
1992-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1993-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f46904ffbe8eec17e678761b048f6ba3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd52f47c7c7042bd1db2d413d4064d68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcb257892d3b7929e5a716d58a9077d6 |
| publicationDate |
1993-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5176908-A |
| titleOfInvention |
Method for the treatment of endotoxic shock in mammal |
| abstract |
The invention is a method of treating endotoxic shock in a mammal which comprises administering to the mammal a therapeutically effective amount of an antagonist to Platelet Activating Factor in combination with a therapeutically effective amount of one or more monoclonal or polyclonal antibodies directed towards either Tumor Necrosis Factor alpha , Interleukin-1 beta , Gamma Interferon, or bacterial cell wall lipopolysaccharides. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2113230-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9732585-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2417943-A1 |
| priorityDate |
1988-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |